Evidence map›Paper›PMID 24777452›Full record

ArticleNature genetics2014

Deep transcriptome profiling of mammalian stem cells supports a regulatory role for retrotransposons in pluripotency maintenance.

Alexandre Fort, Kosuke Hashimoto, Daisuke Yamada, Md Salimullah, Chaman A Keya, Alka Saxena, Alessandro Bonetti, Irina Voineagu, Nicolas Bertin, Anton Kratz and 12 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 169 papers.

0numbers the graph read from it
0cells of the map it votes in
169citing papers in PubMed
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

169 citing papers in PubMed, 319 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

109 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 5 countries.

Alexandre Fort1] Division of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan. [2].
Kosuke Hashimoto1] Division of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan. [2].
Daisuke YamadaLaboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Md SalimullahDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
Chaman A KeyaDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
Alka Saxena1] Division of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan. [2].
Alessandro BonettiDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
Irina Voineagu1] Division of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan. [2].
Nicolas Bertin1] Division of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan. [2].ORCID 0000000298359606
Anton KratzDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
Yukihiko NoroDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
Chee-Hong WongSequencing Technology Group, Joint Genome Institute, Lawrence Berkeley National Laboratory, Walnut Creek, California, USA.
Michiel de HoonDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
Robin AnderssonBioinformatics Centre, Department of Biology and Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.ORCID 000000031516879X
Albin SandelinBioinformatics Centre, Department of Biology and Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
Harukazu SuzukiDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
Chia-Lin WeiSequencing Technology Group, Joint Genome Institute, Lawrence Berkeley National Laboratory, Walnut Creek, California, USA.
Haruhiko KosekiLaboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
FANTOM Consortium
Yuki HasegawaDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
Alistair R R ForrestDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
Piero CarninciDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, Yokohama, Japan.
CE Technologies (United Kingdom) · GBLawrence Berkeley National Laboratory · USRIKEN Center for Integrative Medical Sciences · JPUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The importance of microRNAs and long noncoding RNAs in the regulation of pluripotency has been documented; however, the noncoding components of stem cell gene networks remain largely unknown. Here we investigate the role of noncoding RNAs in the pluripotent state, with particular emphasis on nuclear and retrotransposon-derived transcripts. We have performed deep profiling of the nuclear and cytoplasmic transcriptomes of human and mouse stem cells, identifying a class of previously undetected stem cell-specific transcripts. We show that long terminal repeat (LTR)-derived transcripts contribute extensively to the complexity of the stem cell nuclear transcriptome. Some LTR-derived transcripts are associated with enhancer regions and are likely to be involved in the maintenance of pluripotency.

Indexed as

RetroelementsTranscriptomeAnimalsCell NucleusChromatinCytoplasmEnhancer Elements, GeneticGene Expression ProfilingGene Regulatory NetworksHumansLymphocytesMiceMicroRNAsOligonucleotides, AntisensePluripotent Stem CellsTerminal Repeat SequencesChromatinMicroRNAsOligonucleotides, AntisenseRetroelements

Identifiers

PMID24777452
OpenAlexW2121895515

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.